- Targeted therapy for head and neck cancer🔍
- Low|cost oral metronomic chemotherapy versus intravenous ...🔍
- Cumulative cisplatin dose in concurrent chemoradiotherapy for head ...🔍
- Study supports weekly low|dose cisplatin for advanced head and ...🔍
- CONCURRENT CHEMORADIOTHERAPY IN THE MANAGEMENT ...🔍
- Revisiting Induction Chemotherapy for Head and Neck Cancer🔍
- Treatment with cisplatin concomitantly with radiotherapy for head ...🔍
- A phase I trial combining oral cisplatin 🔍
Optimal regimen of cisplatin in squamous cell carcinoma of head ...
Targeted therapy for head and neck cancer: signaling pathways and ...
... cisplatin regimen in treating head and neck squamous cell carcinoma in mice. ... Zalutumumab plus best supportive care versus best ...
Low-cost oral metronomic chemotherapy versus intravenous ...
patients with cancer of the oral cavity treated with the cisplatin and fluorouracil combination regimen had a median overall survival of only 4 months compared ...
Cumulative cisplatin dose in concurrent chemoradiotherapy for head ...
According to the Longitudinal Oncology Registry of Head and Neck Carcinoma report for the years 2005 to 2010, 70% of patients with HNSCC in the ...
Study supports weekly low-dose cisplatin for advanced head and ...
Patients with locally advanced head and neck squamous cell carcinoma who received weekly low-dose cisplatin with concurrent radiotherapy ...
CONCURRENT CHEMORADIOTHERAPY IN THE MANAGEMENT ...
The use of radiotherapy and concurrent chemotherapy has been explored in the management of squamous cell head and neck cancer for more than 3 decades.
Revisiting Induction Chemotherapy for Head and Neck Cancer
The most studied combination-cisplatin plus fluorouracil (5-FU)-achieves objective responserates of about 80%. In a meta-analysis, induction with platinum/5-FU ...
Treatment with cisplatin concomitantly with radiotherapy for head ...
The specific objective is to ensure patients with locoregionally advanced head and neck squamous cell carcinoma the optimal treatment appropriate for each ...
A phase I trial combining oral cisplatin (CP Ethypharm) with ...
To determine the maximum tolerated dose (MTD) of oral cisplatin (CP Ethypharm®) in combination with radiotherapy in head and neck squamous cell carcinoma ( ...
Optimal regimen of cisplatin in squamous cell carcinoma of head ...
AbstractHead and neck cancers account for more than 550,000 cases and 380,000 deaths annually worldwide and are the 6 th most common cancer type (1).
Final results of a multi-institutional phase II trial of reirradiation with ...
Background: The optimal regimen of chemotherapy and reirradiation (re-XRT) for recurrent head and neck squamous cell carcinoma (HNSCC) is ...
Cisplatin and Radiotherapy in the Treatment of Locally Advanced ...
At present, there is no optimal schedule for treating head ... Radiosensitization of advanced squamous cell carcinoma of the head and neck with cisplatin during ...
Three-Weekly Cisplatin Superior to Weekly Dose in Head and Neck ...
... head and neck squamous cell carcinoma ... Early Intervention, Regular Assessment Can Grasp Symptom Course for Head and Neck Cancer Therapy.
Essential news of current guidelines: head and neck squamous cell ...
High-dose cisplatin 100 mg/m2 given on day 1, 22 and 43 concurrently to radiotherapy (RT) is regarded as the standard of care across the ...
dosage schedule of cisplatin in treatment of Basaloid squamous cell ...
Cisplatin at a dose of 100mg/m2 every three weeks is, by far, the best-proven chemotherapy to be used together with radiation for head/neck ...
Concurrent chemoradiotherapy with cisplatin given once-a-week ...
Background: In locally advanced head and neck squamous cell carcinoma, chemo-radiation with cisplatin 100 mg/m2 administered once every three weeks is the ...
Comparison of Two Cisplatin Regimens for Chemoradiation in ...
Key Words: Head and neck squamous-cell carcinoma, chemoradiation, cisplatin regimens, toxicity, loco-regional control, survival. ANTICANCER RESEARCH 43: 795-800 ...
and nephrotoxicity profile of weekly versus every 3-weekly cisplatin ...
However, its role as fractionated weekly dose has achieved favorable outcome in patients with locally advanced squamous cell carcinoma of head ...
Approaches combining chemotherapy and radiation therapy
BACKGROUND Phase 2 studies suggest that the standard regimen of cisplatin and fluorouracil (PF) plus docetaxel (TPF) improves outcomes in squamous-cell ...
Take a look at the Recent articles - OAText
Concurrent chemoradiation therapy (CCRT) has become the treatment of choice for locally advanced squamous cell carcinoma of head & neck (SCCHN). Multiple ...
Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB ...
... squamous cell carcinoma of the uterine cervix? Findings In this randomized clinical trial of concurrent weekly cisplatin with optimal ...